What is China Health Industries Holdings Financial Strength?
China Health Industries Holdings has the Financial Strength Rank of 4.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its
Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3.
Altman Z-Score.
China Health Industries Holdings has no long-term debt (1).
As of today, China Health Industries Holdings's Altman Z-Score is 13.49.
(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Competitive Comparison of China Health Industries Holdings's Financial Strength
For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Industries Holdings's Financial Strength Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's Financial Strength distribution charts can be found below:
* The bar in red indicates where China Health Industries Holdings's Financial Strength falls into.
China Health Industries Holdings Financial Strength Calculation
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
China Health Industries Holdings's Interest Expense for the
months ended in Dec. 2023 was $0.00 Mil. Its Operating Income for the
months ended in Dec. 2023 was $-0.45 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil.
China Health Industries Holdings's Interest Coverage for the quarter that ended in Dec. 2023 is
| China Health Industries Holdings had no long-term debt (1). |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
China Health Industries Holdings's Debt to Revenue Ratio for the quarter that ended in Dec. 2023 is
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
China Health Industries Holdings has a Z-score of 13.49, indicating it is in Safe Zones. This implies the Z-Score is strong.
Good Sign:
Altman Z-score of 13.49 is strong.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Industries Holdings (China Health Industries Holdings) Business Description
Traded in Other Exchanges
N/A
Address
3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028
China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
Executives
| Sun Xin |
director, 10 percent owner, officer: CEO, CFO and Treasurer |
NO 168 BINBEI STREET, SONBEI DISTRICT, HARBIN, HEI LONG JIANG F4 150000 |
| Hall E Ewing |
director, officer: Secretary |
2737 W BASELINE RD 22, TEMPE AZ 85283 |
| Jack C Robinson |
director |
16304 E COUNTRY SHADOW CT, LILBEAT AZ 85297 |
| Teri S Foster |
director |
402 CANDOVER COURT, KATY TX 77450 |
| Brian Lee Hahn |
director, officer: COO |
422 LAMONT TERRACE, BUFFALO GROVE IL 60089 |
| Dennis Mckee |
10 percent owner |
3522 DOHERTY PLACE, KATY TX 77449 |
| Thomas Allen Bontems |
10 percent owner, officer: President, CEO, CFO and, other: Secretary |
1808 S. 1ST AVENUE, PHONEIX AZ 85003 |
China Health Industries Holdings (China Health Industries Holdings) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHHE has been successfully added to your